Effects of Lowered Dialysate Sodium on Left Ventricle Function and Brain Natriuretic Peptide in Maintenance of Hemodialysis Patients

dc.contributor.author Akyol, A.
dc.contributor.author Akdag, S.
dc.contributor.author Asker, M.
dc.contributor.author Gumrukcuoglu, H. A.
dc.contributor.author Duz, R.
dc.contributor.author Demirel, K. C.
dc.contributor.author Begenik, H.
dc.date.accessioned 2025-05-10T17:28:49Z
dc.date.available 2025-05-10T17:28:49Z
dc.date.issued 2017
dc.description Gumrukcuoglu, Hasan Ali/0000-0002-5972-9870 en_US
dc.description.abstract Introduction: Impaired diastolic flow is characterized by decreased left ventricular (LV) filling diastole, abnormal LV distensibility, or delayed relaxation. B-Type natriuretic peptide (BNP) is an indicator of various cardiovascular diseases and body volume status. The aim of this study was to determine whether the lowering of dialysate sodium (Na) levels is effective on LV systolic and diastolic parameters and BNP in the maintenance of hemodialysis patients. Materials and Methods: The study included 49 chronic hemodialysis patients. Left atrium (LA) diameter and LV ejection fraction, LV systolic and diastolic diameter, deceleration time (DT), pulmonary artery pressure (PAP), inferior vena cava diameter (IVCD), early diastolic transmitral flow (E) and late diastolic transmitral flow (A) velocities, E/A ratio, isovolumic relaxation time, peak early diastolic velocity (E), late diastolic velocity (A) of tissue Doppler mitral annulus, and flow propagation velocity of mitral inflow (V-p) were measured before and 6 months after hemodialysis with low Na dialysate. Results: Six months after low Na hemodialysis, a decrease was observed in echocardiographic parameters such as PAP and IVCD (p < 0.05, p < 0.001, and p < 0.001, respectively). However, a significant difference was not observed in LA diameter. In LV diastolic measurement of E and A waves, E/A ratio, DT, V-p, septal E and A, and lateral E and A exhibited significant improvement by low Na HD. BNP level was significantly reduced (p < 0.001). Conclusions: Lowered dialysate Na concentration improves PAP, IVCD, and LV diastolic properties assessed by mitral inflow filling, tissue Doppler velocity, and mitral inflow velocity propagation. en_US
dc.identifier.doi 10.1177/0960327116639362
dc.identifier.issn 0960-3271
dc.identifier.issn 1477-0903
dc.identifier.scopus 2-s2.0-85008507433
dc.identifier.uri https://doi.org/10.1177/0960327116639362
dc.identifier.uri https://hdl.handle.net/20.500.14720/12156
dc.language.iso en en_US
dc.publisher Sage Publications Ltd en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Dialysate Sodium en_US
dc.subject Left Ventricle Function en_US
dc.subject Brain Natriuretic Peptide en_US
dc.subject Maintenance Hemodialysis en_US
dc.title Effects of Lowered Dialysate Sodium on Left Ventricle Function and Brain Natriuretic Peptide in Maintenance of Hemodialysis Patients en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Gumrukcuoglu, Hasan Ali/0000-0002-5972-9870
gdc.author.scopusid 15051580600
gdc.author.scopusid 24480843500
gdc.author.scopusid 6507138719
gdc.author.scopusid 15047911000
gdc.author.scopusid 56957205400
gdc.author.scopusid 57191572292
gdc.author.scopusid 35520560800
gdc.author.wosid Yaman, Mahmut/Jrw-2481-2023
gdc.author.wosid Begenik, Huseyin/Lkl-8263-2024
gdc.author.wosid Öztürk Keleş, Fatma/Juf-4763-2023
gdc.author.wosid Akdağ, Simay/Isa-2189-2023
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Akyol, A.; Akdag, S.; Asker, M.; Gumrukcuoglu, H. A.; Duz, R.; Demirel, K. C.; Ozturk, F.; Yaman, M.; Sahin, M.; Simsek, H.; Tuncer, M.] Yuzuncu Yil Univ, Dept Cardiol, Van, Turkey; [Begenik, H.] Yuzuncu Yil Univ, Dept Nephrol, Van, Turkey en_US
gdc.description.endpage 134 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 128 en_US
gdc.description.volume 36 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.pmid 27009112
gdc.identifier.wos WOS:000391770400003
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files